Albany, New York, March 14, 2017: It is majorly acknowledged that Cancer is the deadliest disease of the century. The advancements in medical field and years of researches have resulted in developing a variety of treatments for cancer. According to the latest study, Proton Beam Therapy is one of the most superior forms of radiation therapy in the world which is gaining momentum in the U.K. market. This has been broadly analyzed in a study, added to the massive report offerings of Market Research Hub (MRH), titled as “United Kingdom (UK) Proton Therapy Market, Reimbursement Policy and Patients Treated at Proton Facility & Forecast”. According to the research key findings, UK Proton Therapy Market is expected to grow at a CAGR of 82% in coming years.
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=998975
Overall research findings majorly focus on the U.K. market of proton therapy and analyze that the estimated growth is 10 times higher than its existing market in 2016. One of the prime reasons for this market growth is growing incidence of cancer patients in the United Kingdom which creates high demand for the better treatment option. By considering the forecast period of 2009 to 2021, the study encapsulates the major information from four viewpoints, such as UK proton therapy actual market, untapped market, treated patient numbers and untapped patient numbers.
Proton therapy is a type of external-beam radiation treatment, which uses high-energy proton beam for cancer treatment. It painlessly sends radiation through the skin from a machine outside the body. Since many years, Proton Beam Therapy has transformed the treatment of numerous cancers such as pediatric cancers, skull base tumors, brain tumors, breast cancer, prostate cancer and lung cancer etc. Also, it turns out to be a feasible option; mainly in cases where treatment options are limited. Currently, U.K. has only one Proton Therapy facility, at Clatterbridge cancer center and it’s a “low-energy” beam, only suitable for treating people with rare eye cancers.
Furthermore, the research also analyzes that, treating more complex cancers requires a ‘high-energy’ beam, so the NHS covers the cost of referring patients for treatment abroad (especially in the US or Switzerland) when there’s clear indication that this therapy is the finest option. The equipment fitted at the UK’s first proton beam therapy center, will provide cancer patients with the most advanced cancer technology available. Though, this scenario is expected to make a drastic change in the next few years as the United Kingdom will have at least 6 Proton Therapy Centers.
Key companies covered in the report includes:
- IBA Proton Therapy
- Varian Medical Systems
Several companies are opening proton beam therapy centers across the U.K. as the treatment becomes more popular. People who travel abroad from the UK to receive proton beam therapy usually respond well.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free: 866-997-4948 (US-Canada)
Follow Us on: